Chuck Royce acquired 6.95 Thousand Viking Therapeutics shares worth $466 Thousand. That's 0.00% of their equity portfolio (760th largest holding). The first Viking Therapeutics trade was made in Q4 2018. Since then Chuck Royce bought shares one more times and sold shares on two occasions. The stake costed the investor $90.9 Thousand, netting the investor a gain of 412% so far.